TABLE 1.
Metabolite | Nucleotide presence (+) or absence (−) |
Nucleotide effect (p‐value) |
||||
---|---|---|---|---|---|---|
ADP−, GDP− | ADP−, GDP+ | ADP+, GDP− | ADP+, GDP+ | ADP | GDP | |
Oxaloacetate (µM) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | n/a | n/a |
Malate (µM) | 90 ± 3 | 193 ± 24aa | 100 ± 5 | 128 ± 10b | 0.055* | <0.001* |
Aspartate (µM) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | n/a | n/a |
Citrate (µM) | 277 ± 15 | 267 ± 13 | 263 ± 20 | 214 ± 13 | 0.051 | 0.082 |
α‐ketoglutarate (µM) | 162 ± 21 | 59 ± 7a | 221 ± 23 | 203 ± 19bb | < 0.001* | 0.007* |
Mitochondria were energized by 5 mM pyruvate +1 mM [U‐13C] malate and incubated for 20 min under the same conditions used in the studies of Figure 2. Data were analyzed by 2‐factor (ADP × GDP) ANOVA. n = 4 for all values. All metabolites were determined in the same 4 individual mitochondrial preparations.
a p< 0.01, aa p < 0.001 versus ADP‐, GDP‐, b p< 0.01, bb p < 0.001 versus ADP‐, GDP+.
Interaction was significant, so interpretation is limited. Data represent mean ± SE.